We are live on ! Find out more
MYGN icon

Myriad Genetics
MYGN

205 hedge funds and large institutions have $1.98B invested in Myriad Genetics in 2022 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 65 increasing their positions, 74 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

785% more call options, than puts

Call options by funds: $7.18M | Put options by funds: $811K

41% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 22

4% more funds holding

Funds holding: 197 → 205 (+8)

0.53% more ownership

Funds ownership: 98.03% → 98.56% (+0.53%)

8% less capital invested

Capital invested by funds: $2.16B → $1.98B (-$175M)

12% less repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 74

Holders
205
Holders Change
+8
Holders Change %
+4.06%
% of All Funds
3.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
65
Reduced
74
Closed
22
Calls
$7.18M
Puts
$811K
Net Calls
+$6.37M
Net Calls Change
-$1.84M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$19.7M
2
CCM
Camber Capital Management
Massachusetts
+$19.2M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$8.22M
4
Bank of America
Bank of America
North Carolina
+$6.91M
5
Artisan Partners
Artisan Partners
Wisconsin
+$4.25M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$22.7M
2
Goldman Sachs
Goldman Sachs
New York
-$7.08M
3
State Street
State Street
Massachusetts
-$5.48M
4
N
Nuveen
North Carolina
-$4.44M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$4.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
CAL
176
Capital Analysts LLC
Pennsylvania
$5K – – –
S
177
Surevest
California
$5K – – –
PFS
178
Prospera Financial Services
Texas
$5K +$5.12K +200 New
CTB
179
Country Trust Bank
Illinois
$4K – – –
HNB
180
Huntington National Bank
Ohio
$4K – – –
SN
181
Sittner & Nelson
Oregon
$4K – – –
Northwestern Mutual Wealth Management
182
Northwestern Mutual Wealth Management
Wisconsin
$4K +$3.84K +150 New
Macquarie Group
183
Macquarie Group
Australia
$3.44K – – –
CWC
184
Carolinas Wealth Consulting
North Carolina
$3K – – –
DBG
185
De Burlo Group
Massachusetts
$2.52K +$2.56K +100 New
AssetMark Inc
186
AssetMark Inc
California
$2K -$102 -4 -4%
GWS
187
Glassman Wealth Services
Virginia
$2K – – –
PA
188
Parallel Advisors
California
$2K – – –
QCG
189
Quadrant Capital Group
Ohio
$2K – – –
S
190
SignatureFD
Georgia
$2K – – –
TFO
191
Tarbox Family Office
California
$2K – – –
CWP
192
Concord Wealth Partners
Virginia
$2K +$1.87K +73 +304%
APA
193
American Portfolios Advisors
New York
$1.69K – – –
KFS
194
Kelly Financial Services
Massachusetts
$1.51K – – –
STCOSD
195
Sageworth Trust Company of South Dakota
South Dakota
$1K -$4.76K -186 -82%
TFS
196
TrustCore Financial Services
Tennessee
$1K – – –
GRP
197
Global Retirement Partners
California
$1K +$947 +37 New
MAM
198
Meeder Asset Management
Ohio
$1K +$1.1K +43 New
TCM
199
Tieton Capital Management
Washington
– -$3.27M -118,456 Closed
CW
200
Connectus Wealth
Ohio
– -$2.34M -84,754 Closed
6 7
8
9 10

MYGN Hedge Fund Activity: Q1 2022 in Review

205 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Myriad Genetics (MYGN) for Q1 2022, worth a combined $1.98B — down 8.1% from $2.16B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new MYGN positions and 22 closed out — a net gain of 9 holders — while 65 added to existing stakes and 74 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $19.7M. The largest seller was Millennium Management, cutting an estimated $22.7M.

  • 205 institutional investors held Myriad Genetics (MYGN) as of Q1 2022, up from 197 in Q4 2021.
  • Funds reported $1.98B of Myriad Genetics stock for Q1 2022, down 8.1% quarter-over-quarter.
  • 31 funds opened new Myriad Genetics positions in Q1 2022 and 22 closed out, a net change of +9 holders.
  • The largest Myriad Genetics buyer in Q1 2022 was Wellington Management Group, an estimated $19.7M added.
  • The largest Myriad Genetics seller in Q1 2022 was Millennium Management, an estimated $22.7M sold.

Based on aggregated 13F filings for Q1 2022.